News

Nearly Half of Migraine Sufferers Report Unmet Medical Needs


 

FROM THE ANNUAL MEETING OF THE AMERICAN HEADACHE SOCIETY

The AMPP study is funded by the American Headache Society through grants from Ortho-McNeil Neurologics and Merck Sharp & Dohme Corp., a subsidiary of Merck.

Dr. Buse has received research support from Allergan Pharmaceuticals, Iroko Pharmaceuticals, MAP Pharmaceuticals, and Merck.

Pages

Recommended Reading

Cardiovascular Effects of Fingolimod Are Mostly Transient
MDedge Internal Medicine
Genetic Marker Predicts Taxane-Induced Neuropathy
MDedge Internal Medicine
Scans Detect Brain Damage in "Mild" Blast-Related TBI
MDedge Internal Medicine
Video Report: Adult Migraine, Childhood Abuse?
MDedge Internal Medicine
Multimodal Approach Advocated for Nonadherent Headache Patients
MDedge Internal Medicine
Stave Off Damage From Status Epilepticus With Seizure Algorithm
MDedge Internal Medicine
Statin Cuts Recurrent Stroke Risk Similarly in Diabetic, Nondiabetic Patients
MDedge Internal Medicine
FDA Approves First Potassium Channel Opener for Seizures
MDedge Internal Medicine
Attention Turns to Concussions' Psychiatric Effects in Athletes
MDedge Internal Medicine
Posttraumatic Headache Tougher to Treat Than Migraine
MDedge Internal Medicine